Differential impact of mammalian target of rapamycin inhibition on CD4+CD25+Foxp3+ regulatory T cells compared with conventional CD4+ T cells
Robert Zeiser(University of Freiburg), Robert S. Negrin(Stanford Blood Center)
Cited by 393
Related Papers
Immune modulatory effects of oncogenic KRAS in cancer
|Nature Communications|2020|373
The Nlrp3 inflammasome regulates acute graft-versus-host disease
|The Journal of Experimental Medicine|2013|233
Regulation of murine NK cell exhaustion through the activation of the DNA damage repair pathway
|JCI Insight|2019|92
Molecular Imaging of Chimeric Antigen Receptor T Cells by ICOS-ImmunoPET
|Clinical Cancer Research|2020|85